NCT06294522

Reconstruction of Nasal Floor for Three-dimensional Repair of Alveolar Cleft

Name: Clinical Trial NCT06294522
Creator: Tanta University
Keywords: Alveolar Cleft, reconstruction of alveolar cleft, procedure, clinical trial, Egypt

Lecturer of Oral and Maxillofacial Surgery

Tanta University·ClinicalTrials.gov·procedureCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Alveolar Cleft
Drug/Device/Intervention: reconstruction of alveolar cleft
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: Tanta University
Location: Tanta, Egypt

Timeline & enrollment

Phase: N/A
Start date: Jul 20, 2023
End date: Feb 16, 2024
Enrollment: 16 participants

Primary outcome

recurrence of oronasal fistula,volume of alveolar cleft after reconstruction,density of bone

Summary

reconstruction of alveolar cleft with autogenous bone after elevation of mucoperiosteal flap and suturing of nasal floor and palatal flap

ICD-10 classifications

Cleft palateCleft palate, unspecifiedCleft soft palateOther branchial cleft malformationsCleft uvula

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06294522
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06294522 through Pure Global AI's free database. This phase not specified trial is sponsored by Tanta University and is currently Completed. The study focuses on Alveolar Cleft. Target enrollment is 16 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.